GENEVA -- The World Health Organization has authorized the first mpox vaccine for children, a decision experts hope will help make immunizations more widely available to one of the hardest-hit populations during the ongoing outbreaks of the disease in Congo and elsewhere in Africa.

The World Health Organization approved the first mpox vaccine for children, aiming to curb its spread in affected areas like Congo. The move follows a significant increase in cases among minors and recognizes the vulnerability of children to the disease,

The World Health Organisation (WHO) has granted emergency use listing (EUL) for the LC16m8 mpox vaccine. This would be the

The WHO has granted emergency use approval for the LC16m8 vaccine against mpox, developed by Japanese company KM Biologics. This move aims to curb the global surge in cases, especially in Africa.

The World Health Organization Tuesday granted emergency use authorization for the second mpox vaccine. The LC16m8 vaccine from Japan's KM Biologics is the second since WHO declared mpox a health emergency in August.

The vaccine is the second to be approved by the UN agency and the first approved for children aged one and older. View on euronews